Kisspeptin-10

Research

Kisspeptin-10

Category
Sexual Health
Aliases
Metastin 45-54, KP-10
Administration
Subcutaneous injection, IV infusion (research)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Effects on the hormonal cascade begin quickly at the receptor level, though felt changes are typically minimal this early.

  2. 2

    3–4 Weeks

    Some users report subtle shifts in energy or libido as downstream hormone levels adjust.

  3. 3

    5–7 Weeks

    Continued use may be associated with steadier reproductive hormone signaling.

  4. 4

    8–10 Weeks

    Fertility-focused users at this stage often begin monitoring relevant lab markers alongside any felt changes.

  5. 5

    11–15 Weeks

    Effects, where present, tend to be gradual rather than sudden.

  6. 6

    16–20 Weeks

    Long-term users typically describe a steadier overall sense of hormonal wellbeing.

  7. 7

    21–24 Weeks

    By this stage, most users are evaluating outcomes in consultation with a physician rather than relying on felt sensation alone.

⚠️ Research context only. This is not medical advice and results are not guaranteed.